Gnetofuran A Enhances Osteoblast Differentiation through the p38 Signaling Pathway
Meiyu Piao1, Lulu Yao1, SeonJu Park2
1Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju 61186, Republic of Korea.
Biomolecules & Therapeutics
|October 14, 2025
Summary
Gnetofuran A, a compound from Gnetum latifolium, promotes osteoblast differentiation by upregulating key genes and transcription factors. This suggests Gnetofuran A as a potential therapeutic for osteoporosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Gnetofuran A, isolated from Gnetum latifolium, exhibits anti-inflammatory properties by inhibiting TNF-α.
- The role of Gnetofuran A in osteoblast differentiation is currently unknown.
- Osteoblast differentiation is crucial for bone formation and health.
Purpose of the Study:
- To investigate the effects of Gnetofuran A on osteoblast differentiation.
- To elucidate the molecular mechanisms underlying Gnetofuran A's action in osteoblasts.
- To explore Gnetofuran A as a potential therapeutic agent for bone-related disorders.
Main Methods:
- Cell culture of osteoblasts.
- Quantitative real-time PCR to measure osteogenic gene expression (ALP, OC).
- Western blotting to assess protein levels of Runx2 and Osterix.
- p38 MAPK signaling pathway analysis.
- Molecular docking simulation.
Main Results:
- Gnetofuran A significantly enhanced osteoblast differentiation.
- Upregulation of osteogenic gene mRNA levels, including alkaline phosphatase (ALP) and osteocalcin (OC).
- Increased protein expression of key transcription factors, Runx2 and Osterix.
- Evidence suggests the involvement of the p38 MAPK signaling pathway.
- Docking analysis indicated a potential interaction between Gnetofuran A and p38.
Conclusions:
- Gnetofuran A promotes osteoblast differentiation through the p38 MAPK signaling pathway.
- Gnetofuran A upregulates critical genes and transcription factors essential for osteogenesis.
- Gnetofuran A represents a novel therapeutic candidate for osteoporosis and other bone diseases.
Related Concept Videos
01:16TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
01:19Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K